News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Five Prime Therapeutics, Inc. (FPRX) Announces The Full Exercise Of The Underwriters' Option To Purchase Additional Shares


2/10/2014 9:24:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) announced today the full exercise of the underwriters' option to purchase an additional 450,000 shares of common stock. The option was granted in connection with the Company's previously announced underwritten public offering of 3,000,000 shares of common stock. With the full exercise of the underwriters' option, the total number of shares sold in the offering was 3,450,000 shares, resulting in aggregate gross proceeds of $43,125,000, before underwriting discounts, commissions and estimated expenses.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES